Israeli AI Biotech Immunai Teams Up with Bristol Myers Squibb to Advance Drug Development
Israeli AI Biotech Immunai partners with Bristol Myers Squibb, utilizing its AMICA-OS platform to accelerate drug development. This collaboration promises to.
















Real-time breaking news coverage from Israel and the Middle East. Stay informed with the latest developments as they happen.
Israeli AI Biotech Immunai partners with Bristol Myers Squibb, utilizing its AMICA-OS platform to accelerate drug development. This collaboration promises to.
Israeli biotech MeMed receives $2 million grant for AI-driven diagnostics biobank to accelerate development of high-risk patient tools.
An Israeli biotech breakthrough from the Weizmann Institute of Science allows doctors to track immunity to new viruses in minutes, crucial for future pandemic.
Israeli biotech Amorphical announces breakthrough Crohn’s therapy, achieving sustained remission with nano-amorphous Calcium Carbonate in Phase 2 trial at.
BioLineRx secures crucial U.S. patent for groundbreaking GLIX1 cancer therapy, targeting 90% of cancers. Exciting developments for Israeli biotech.
Israeli biotech CollPlant opens U.S. hub to expand rhCollagen distribution. New facility to enhance North American presence with cGMP compliance and AI
Israeli biotech company BioLineRx partners with Norwegian firm Hemispherian AS to develop new brain cancer drug GLIX1, targeting cancer cells' DNA repair. FDA
Israeli biotech CannaLean's CLC-01, a CBD-chitosan therapy for high LDL cholesterol, achieved a 28% reduction in a 12-week trial, showing safety and.
Israeli-US focused ultrasound company Insightec spins out Lotus Neuro, a new biotech firm to speed brain-targeted drug delivery for neuro-oncology indications.
Israeli startup OncoHost wins Proteomics Innovation of the Year at the 2025 BioTech Breakthrough Awards. Discover how their groundbreaking PROphet platform is